Could a common Alzheimer's drug help stroke survivors move again?
NCT ID NCT02144584
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study is testing whether memantine, a drug already used for Alzheimer's, can improve arm and leg function after an ischemic stroke. Twenty participants with arm weakness will receive either memantine or a placebo for several weeks. The study measures motor skills and tracks any side effects to see if the drug is safe and worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
memantine (Namenda XR)
What this could lead to
If it works, this could point toward a treatment to help people regain movement after a stroke.
What could go wrong
This is a very early, small pilot study with only 20 people. It is designed to test feasibility, not prove effectiveness, so results may not lead to a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Utah
Salt Lake City, Utah, 84132, United States